Abstract
An acellular pertussis vaccine JNIH-6 containing pertussis toxin and filamentous hemagglutinin was evaluated in adult volunteers with regard to adverse reactions and antibody response. Adverse reactions were few and mild. A late onset local reaction was seen in 22 of the 47 vaccinees (47 %) as compared to none of the 20 subjects receiving a placebo, the carrier solution of aluminium phosphate of the vaccine. The reaction, which manifested itself on the 6th to 8th day after vaccination, consisted in all cases of an induration and/or swelling considered insignificant by the majority of the subjects. The reaction was only found in vaccinees receiving a first dose of vaccine and was independent of the prevaccination antitoxin level. The vaccine induced a highly satisfactory antibody response to both filamentous hemagglutinin and pertussis toxin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Whooping Cough Immunization Committee, Medical Research Council: Vaccination against whooping cough. British Medical Journal 1959, i: 994–1000.
Cody, C. L., Baraff, L. J., Cherry, J. D., Marcy, S. M., Manclark, C. R.: Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981, 68: 650–660.
Miller, D. L., Ross, E. M., Alderslade, R., Bellman, M. H., Brawson, N. S. B.: Pertussis immunization and serious acute neurological illness in children. British Medical Journal 1981, 282: 1595–1599.
Arai, H., Sato, Y.: Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor fromBordetella pertussis. Biochemical Biophysical Acta 1976, 444: 765–782.
Sato, Y., Kimura, M., Fukumi, H.: Development of a pertussis component vaccine in Japan. Lancet 1984, i: 122–126.
Aoyama, T., Murase, Y., Kato, T., Iwata, T.: Efficacy of an acellular pertussis vaccine in Japan. Journal of Pediatrics 1985, 107: 180–183.
Griffiths, E., Kreeftenberg, J. G.: Developments in pertussis vaccines: memorandum from a WHO Meeting. Bulletin of the WHO 1985, 63: 241–248.
Granström, M., Lindberg, A. A., Askelöf, P., Hederstedt, B.: Detection of antibodies in human serum against the fimbrial heamagglutinin ofBordetella pertussis by enzyme-linked immunosorbent assay. Journal of Medical Microbiology 1982, 15: 85–96.
Granström, M., Granström, G., Lindfors, A., Askelöf, P.: Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. Journal of Infectious Diseases 1982, 146: 741–745.
Gillenius, P., Jäätmaa, E., Askelöf, P., Granström, M., Tiru, M.: The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. Journal of Biological Standardization 1985, 13: 61–66.
Granström, M., Granström, G., Gillenius, P., Askelöf, P.: Neutralizing antibodies to pertussis toxin in whooping cough. Journal of Infectious Diseases 1985, 151: 646–649.
Linnemann, C. C., Ramundo, N., Perlstein, P. H., Minton, S. D., Englender, G. S., McCormick, J. B., Hayes, P. S.: Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975, i: 540–544.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Granström, M., Thorén, M., Blennow, M. et al. Acellular pertussis vaccine in adults: Adverse reactions and immune response. Eur. J, Clin. Microbiol. 6, 18–21 (1987). https://doi.org/10.1007/BF02097184
Issue Date:
DOI: https://doi.org/10.1007/BF02097184